Introduction
Although metronidazole is active against most obligate anaerobes it has little useful clinical activity against facultative bacteria. One exception is Gardnerella vaginalis, a facultative Gram-variable bacillus strongly associated with non-specific vaginitis.' While metronidazole is only moderately active against G vaginalis in vitro (reported minimum inhibitory concentrations (MICs) ranging from 2 mg/l to >50 mg/l) it is very effective in vivo against vaginitis associated with G vaginalis.2 I Several hypotheses have been put forward to explain this discrepancy. Obligate anaerobes may play some part, indeed possibly the major part, in the aetiology of gardnerella-associated vaginitis, either by providing essential nutrients or by inhibition of host defence mechanisms. The efficacy of metronidazole is, therefore, related to its effect on these organisms rather than on G vaginalis. 
Discussion
We agree with other workers,5-7 who found that while metronidazole was moderately active against G vaginalis its hydroxy metabolite was far more so. Gardnerellas are alone among facultative bacteria in being so sensitive to these agents. Whether 0 vaginalis shares with obligate anaerobes the capacity to reduce metronidazole"I and whether the greater activity of the hydroxy metabolite is related to greater uptake or more effective killing remains to be determined. It does seem likely that the greater activity of the hydroxy metabolite against C vaginalis is specific for this organism as we did not find it to be any more active than metronidazole against other facultative bacteria. Ralph and Amatnieks5 found it to be less active than metronidazole against Bacteroides spp.
MICs of metronidazole were generally lower when tested anaerobically than in CO2 but this difference was less noticeable with the hydroxy metabolite. Our MICs are somewhat higher than those reported by Ralph and Amatnieks.5
Three hours after ingestion the metabolite accounted for about 10% of total drug in the plasma rising to 30-40% at 24 hours. This increase in the proportion of the metabolite compared with a steady fall in the concentration of metronidazole over the same time.'0 There was some evidence of a steady rise in concentrations of hydroxy metabolite in the patient rece;ving metronidazole for three days. The hydroxy metabolite was the major product in the urine, with high concentrations being reached 24 hours after a 400-mg dose of metronidazole. After 400 mg metronidazole the plasma concentrations of both compounds were lower than the MICs for most G vaginalis strains. With the 2-g dose, however, plasma concentrations of these agents were above the MICs for the more sensitive strains. The urine concentrations of the hydroxy metabolite were far in excess of the MICs of most strains tested. 
